RANOLAZINE
| Brand name | ASPRUZYO SPRINKLE |
|---|---|
| Active ingredient | RANOLAZINE |
| Strength | 500MG |
| Dosage form | GRANULE, EXTENDED RELEASE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | February 2022 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 11510878 | January 2038 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.